SCHEMBL30587152

SCHEMBL30587152

COc1cc(C(=O)Nc2ccc(-c3nnc(-c4ccccc4)o3)cc2)ccn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.60
HPGD P15428 9/20 0.60
HSD17B10 Q99714 8/20 0.60
TSHR P16473 5/20 0.60
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
ALOX15 P16050 2/20 0.60
KDM4E B2RXH2 7/20 0.59
MAPT P10636 7/20 0.59
NPSR1 Q6W5P4 6/20 0.59
CYP2C9 P11712 3/20 0.59
CYP2C19 P33261 3/20 0.59
CYP3A4 P08684 2/20 0.59
HIF1A Q16665 1/20 0.59
KCNK3 O14649 1/20 0.56
KCNK9 Q9NPC2 1/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPK1 P28482 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24473982 1.00 ALDH1A1 (0.60) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL26078553 0.85 ALDH1A1 (0.64) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL3373348 0.84 KCNK3 (0.74) NPC1RAB9ASMN1; SMN2KCNK3KCNK9
SCHEMBL30587153 0.83 TSHR (0.64) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL24473977 0.83 TSHR (0.64) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL24474001 0.80 SMN1; SMN2 (0.67) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL18886198 0.79 KCNK3 (0.70) ALDH1A1HPGDTSHRNPC1RAB9A
SCHEMBL8770856 0.79 KDM4E (0.83) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL8770855 0.78 NPC1 (0.74) ALDH1A1HPGDHSD17B10TSHRNPC1
SCHEMBL26078526 0.77 ALDH1A1 (0.59) ALDH1A1HPGDHSD17B10TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN claimed
CN-116457353-A N-substituted 4- (5-phenyl-1, 3, 4-oxadiazol-2-yl) anilines for the treatment and prophylaxis of hepatitis b virus infections 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed